Citi raised the firm’s price target on Colgate-Palmolive to $90 from $85 and keeps a Buy rating on the shares. After two years of above-average organic sales growth across the beverages and household and personal care group on outsized pricing with limited elasticity impacts, and recovery in gross margins in 2023 on moderating commodities, Citi sees a return to historical growth levels in 2024, with a few exceptions, the analyst tells investors in a research note. 2024, the firm believes the key theme will be mean reversion, with names able to retain above-average and above-peer trends likely to outperform, together with names showing positive inflections post temporary impacts. Citi’s top pick in the space going into 2024 is Clorox (CLX).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CL:
- Unusually active option classes on open November 29th
- Colgate-Palmolive price target raised to $88 from $83 at JPMorgan
- Colgate Palmolive put volume heavy and directionally bearish
- Oracle upgraded, Southwest downgraded: Wall Street’s top analyst calls
- Colgate-Palmolive initiated with a Buy at Jefferies